Advanced Enzyme Technologies Ltd (ADEN)

Currency in INR
305.20
+2.20(+0.73%)
Closed·
Advertisement
ADEN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
302.00307.65
52 wk Range
251.95419.00
Key Statistics
Bid/Ask
306.00 / 306.25
Prev. Close
303
Open
303
Day's Range
302-307.65
52 wk Range
251.95-419
Volume
188.6K
Average Volume (3m)
320.8K
1-Year Change
-3.616%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADEN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
370.00
Upside
+21.23%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 370.00
(+21.23% Upside)

Advanced Enzyme Technologies Ltd Earnings Call Summary for Q1/2027

  • Q1 FY2027 revenue rose 2% YoY to INR 1,898M, but EBITDA fell 10% to INR 510M amid margin pressure and INR 100M sales reversal impact.
  • Stock dropped 9.19% post-results to $294.55 before recovering to $302; trades at P/E of 10.4, below fair value per InvestingPro analysis.
  • Management guides full-year revenue growth above 12% with EBITDA margins recovering to 30%, despite softer Q1 start and U.S. market weakness.
  • Bioprocessing surged 30% YoY and specialized manufacturing up 41%, offsetting 7% decline in human healthcare segment (60% of revenue).
  • Board approved INR 697M buyback starting August 14, 2026 at INR 500/share; plans INR 123 crore capex for R&D and growth initiatives.
Last Updated: 12/08/2026, 13:10
Read Full Transcript

Earnings

Latest Release
08/08/2026
EPS / Forecast
3.31 / --
Revenue / Forecast
2.03B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 14.80%
Dividend Yield
0.45%
Industry Median 0.72%
Annualised payout
1.35
Paid annually
5-Years Growth
+42.83%
Growth Streak

Compare ADEN to Peers and Sector

Metrics to compare
ADEN
Peers
Sector
Relationship
P/E Ratio
20.5x25.0x4.3x
PEG Ratio
0.98−0.180.00
Price/Book
2.1x0.8x1.6x
Price / LTM Sales
4.5x0.8x1.3x
Upside (Analyst Target)
20.9%11.5%36.1%
Fair Value Upside
Unlock3.3%2.0%Unlock

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.

Industry
Chemicals
Employees
409
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.42M3.95%1.35B
Other Institutional Investors
69.48M62.05%21.23B
Public Companies & Retail Investors
38.07M34.00%11.64B
Total
111.98M100.00%34.22B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
OrbiMed Advisors LLC12.06%13,509,5224,128,510
Orbimed Asia Partners III, L.P.12.06%13,509,5224,128,510

People Also Watch

2,092.70
BAMN
-0.52%
6,918.50
MTAR
-2.99%
428.15
MISR
-2.14%

FAQ

What Is the Advanced Enzyme Tech (NSE: ADEN) Share Price Today?

The Advanced Enzyme Tech stock price today is 305.20 INR.

What Stock Exchange Does Advanced Enzyme Tech (ADEN) Trade On?

Advanced Enzyme Tech is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Advanced Enzyme Tech?

The stock symbol (also called a 'ticker') for Advanced Enzyme Tech is "ADEN."

Does Advanced Enzyme Tech Pay Dividends? What’s The Current ADEN Dividend Yield?

Yes, ADEN Pays Dividends to its Shareholders. The current Advanced Enzyme Tech dividend yield is 0.44%.

What Is the Current Advanced Enzyme Tech Market Capitalisation?

As of today, Advanced Enzyme Tech (NSE: ADEN) market cap is 34.18B INR.

What Is Advanced Enzyme Tech's (ADEN) Earnings Per Share (TTM)?

The Advanced Enzyme Tech EPS is currently 14.80 (Trailing Twelve Months).

When Is the Next Advanced Enzyme Tech Earnings Date?

Advanced Enzyme Tech's next earnings report will be released on 06/11/2026.

Is ADEN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Advanced Enzyme Tech moving averages and other technical indicators, the daily buy/sell signal for ADEN stock is Strong Sell.

How Many Times Has Advanced Enzyme Tech Stock Split?

Advanced Enzyme Tech has split 1 times. (See the ADEN stock split history page for full effective split date and price information.)

How Many Employees Does Advanced Enzyme Tech Have?

Advanced Enzyme Tech has 409 employees, based on their latest Companies House report.

What is the current trading status of Advanced Enzyme Tech (NSE: ADEN)?

As of 19/08/2026, Advanced Enzyme Tech (ADEN) is trading at a share price of 305.20 INR, with a previous close of 303.00 INR. The stock has fluctuated within a day range of 302.00 INR to 307.65 INR, while its 52-week range spans from 251.95 INR to 419.00 INR.

What Is Advanced Enzyme Tech (ADEN) Price Target According to Analysts?

The average 12-month price target for Advanced Enzyme Tech is 370.00 INR, with a high estimate of 370 INR and a low estimate of 370 INR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +21.23% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.